Revolution Medicines, Inc. (RVMD) /
The cash flow of Revolution Medicines, Inc. over the past 8 years
Chart Revolution Medicines, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2018–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, Revolution Medicines, Inc.'s operating cash flow was -$897.74M and its capital expenditures $15.99M, leaving free cash flow of -$913.73M. Free cash flow was below zero in all 8 years shown. It ranged from -$913.73M in fiscal 2025 to -$286K in fiscal 2018. Capital expenditures were highest in fiscal 2025, at $15.99M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$897.74M | $15.99M | -$913.73M |
| 2024ended Dec 31, 2024 | -$557.44M | $10.31M | -$567.74M |
| 2023ended Dec 31, 2023 | -$350.57M | $7.73M | -$358.3M |
| 2022ended Dec 31, 2022 | -$224.4M | $10.82M | -$235.22M |
| 2021ended Dec 31, 2021 | -$147.18M | $6.53M | -$153.71M |
| 2020ended Dec 31, 2020 | -$100.06M | $2.93M | -$103M |
| 2019ended Dec 31, 2019 | -$49.62M | $2.59M | -$52.2M |
| 2018ended Dec 31, 2018 | $1.21M | $1.5M | -$286K |
Fiscal years as Revolution Medicines, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Revolution Medicines, Inc.
- The revenue of Revolution Medicines, Inc.
- The profitability of Revolution Medicines, Inc.
- The debt of Revolution Medicines, Inc.
- All of Revolution Medicines, Inc.'s financials, charted
Companies of a similar size
- ELTHE ESTEE LAUDER COMPANIES INC.
- NBISNEBIUS GROUP N.V.
- PRUPRUDENTIAL FINANCIAL INC
- SYYSysco Corporation
- STMSTMicroelectronics N.V.
Not investment advice. This page shows what Revolution Medicines, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.